ARTICLE | Product Development
Repurposing candidates for COVID-19 from UCSF, Aldeyra
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 25, 2020 1:46 AM UTC
Updated on Mar 26, 2020 at 2:17 AM UTC
A UCSF team has keyed in on more than five dozen compounds against nearly as many targets that could be repurposed to target the virus behind COVID-19.
Meanwhile, a repurposing screen by Aldeyra could yield further antiviral candidates as well as anti-inflammatory therapies to mitigate excessive immune responses against the virus...